These therapeutic failures may partially be related to an enhanced MT overexpression in tumour cells, although the involvement of MT in conferring resistance to chemotherapeutics still remains under discussion (Chin et al, 1993; Hishikawa et al, 1997; Okazaki et al, 1998; Cherian et al, 2003). This evidence concerns the gene MCAT and neoplasm.